A double blind, randomized, placebo-controlled, parallel study to evaluate the efficacy and safety of Androgel [testosterone], as an adjunct to oral hypoglycemic therapy, in the treatment of hypogonadal and low testosterone men with type 2 diabetes.
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2015
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacodynamics
- 07 Sep 2007 Status changed from in progress to completed.
- 12 Jan 2007 Status change
- 19 Nov 2005 New trial record.